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Objective. ,e purpose of this study was to demonstrate the feasibility of using hyperpolarized carbon-13 (13C) metabolic imaging
with [1-13C]-labeled pyruvate for evaluating real-time in vivo metabolism of orthotopic diffuse intrinsic pontine glioma (DIPG)
xenografts.Materials andMethods. 3D 13Cmagnetic resonance spectroscopic imaging (MRSI) data were acquired on a 3Tscanner
from 8 rats that had been implanted with human-derived DIPG cells in the brainstem and 5 healthy controls, following injection of
2.5mL (100mM) hyperpolarized [1-13C]-pyruvate. Results. Anatomical images from DIPG-bearing rats characteristically
exhibited T2-hyperintensity throughout the cerebellum and pons that was not accompanied by contrast enhancement. Evaluation
of real-time in vivo 13C spectroscopic data revealed ratios of lactate-to-pyruvate (p< 0.002), lactate-to-total carbon (p< 0.002),
and normalized lactate (p< 0.002) that were significantly higher in T2 lesions harboring tumor relative to corresponding values of
healthy normal brain. Elevated levels of lactate in lesions demonstrated a distinct metabolic profile that was associated with
infiltrative, viable tumor recapitulating the histopathology of pediatric DIPG. Conclusions. Results from this study characterized
pyruvate and lactate metabolism in orthotopic DIPG xenografts and suggest that hyperpolarized 13C MRSI may serve as
a noninvasive imaging technique for in vivo monitoring of biochemical processes in patients with DIPG.
1. Introduction
Diffuse intrinsic pontine glioma (DIPG) comprises a heteroge-
neous class of childhood brainstem cancers that defy molecular
stratification and surgical intervention because of their sensitive
location. After forming in the pons, this relatively inaccessible
disease often undergoes rapid growth that is characterized by
diffuse infiltration across the midline through healthy tissue.
Despite decades of clinical trials investigating the efficacy of
novel treatment regimens, DIPG remains the leading cause of
death among pediatric patients with central nervous system
cancers and carries an average survival of only 9 months [1].
Magnetic resonance imaging (MRI) serves as the standard
modality for diagnosing DIPG and monitoring disease status
in response to treatment [2]. While conventional MRI pro-
vides information regarding anatomical changes, its prog-
nostic value and ability to assess physiologic or functional
alterations associated with therapeutic efficacy are highly
limited [3]. Attempts at using positron emission tomography
to evaluate DIPG metabolism have also presented challenges
owing to the risks of ionizing radiation exposure [4, 5]. Given
the heterogeneous presentation of the disease on imaging,
which lacks features for stratifying aggressiveness [6], the
development of noninvasive metabolic imaging methods may
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enhance the evaluation of molecular characteristics as well as
response to therapy.
Representing a novel advance in solid state physics,
dissolution dynamic nuclear polarization (d-DNP) enables
the acquisition of carbon-13 (13C) magnetic resonance data
with an appreciable gain in sensitivity over conventional
methods [7]. A phase I first-in-human study using hyper-
polarized 13C magnetic resonance spectroscopic imaging
(MRSI) has already demonstrated the safety and feasibility of
such technology for probing real-time metabolism in
prostate cancer patients [8]. ,e purpose of this study was to
explore the feasibility of using hyperpolarized 13C metabolic
imaging with [1-13C]-pyruvate for evaluating real-time in
vivo metabolism of orthotopic DIPG xenografts.
2. Materials and Methods
Eight six-week-old male athymic rats (rnu/rnu, homozy-
gous, and median weight� 290 g) purchased from Harlan
(Indianapolis, IN) were implanted with patient-derived
human DIPG cells (SF8628) in the brainstem to create an
orthotopic DIPG model, while 5 healthy rats served as ex-
perimental controls. ,e details of the cell culture and in-
tracranial implantation procedures have been described
elsewhere [9]. Study procedures were approved by the In-
stitutional Animal Care and Use Committee.
All animals were scanned on a 3TclinicalMRI system (GE
Healthcare, Waukesha, WI, USA) equipped with a custom-
designed 1H/13C rat coil on approximately the 58th day after
tumor implantation. ,e body temperature was maintained
using a heated pad positioned inside the RF coil. Anesthesia
was maintained with a constant delivery of 1.5% isoflurane.
For the polarization of pyruvate, a 35 μL of [1-13C]-pyruvate
mixed with 15mM OX063 trityl radical (GE Healthcare,
Oslo, Norway), and 1.5mM gadolinium (Gd)-DOTA was
polarized using a HyperSense® (Oxford Instruments,
Abingdon, UK) [7, 10]. After 60 minutes of microwave
irradiation, the mixture was dissolved in a saline solution
with 5.96 g/L Tris (40mM), 4.00 g/L NaOH (100mM), and
0.1mg/L Na2 ethylenediaminetetraacetic acid. ,e final
solution had a concentration of 100mM pyruvate, and
pH∼7.5. 2.7mL of the dissolved pyruvate solution was
injected into the tail vein of the rats over 10 s duration.
,e following 1H and 13C data were acquired in sequence
for each scan: (1) axial T2-weighted images using a fast spin-
echo sequence (echo time/repetition time� 60/4000ms, 8 cm
field of view, 256× 256 matrix, and 2mm slice thickness), (2)
compressed-sensing 13C 3D MRSI data (echo time/repetition
time� 140/215ms, phase encoding in x and y axes, flyback
echo-planar readout in z-axis, 20×16×16 matrix, and
2× 2× 5.4mm spatial resolution) [11] acquired at 20 s from
the start of the pyruvate injection, and (3) axial T1-weighted
images using a spin-echo sequence (echo time/repetition
time� 10/700ms, 8 cm field of view, 320×192 matrix, and
1.2mm slice thickness) after the injection of 0.2mmol/kg
Gd-DTPA.
,e methods for processing 13C MRSI data have been
described previously [11]. For quantification of 13C me-
tabolites, the ratio of lactate-to-pyruvate and lactate-to-total
carbon (tC: sum of lactate, pyruvate-hydrate, alanine, and
pyruvate) was calculated. In addition, the lactate and py-
ruvate signals in the brainstem were normalized with respect
to the relative signals of the normal brain in the supra-
tentorial region (Figure 1(a)). ROIs were manually con-
toured on T2-weighted images for the T2-hyperintense
lesion, and the percentage of T2 lesion volume was calculated
for each voxel. Comparison of mean 13C parameters from
the T2-hyperintense lesion (voxels with >75% T2 lesion) and
similar region of the infratentorial brain of healthy control
animals was performed using the Mann–Whitney rank-sum
test. In order to evaluate the spatial variation of 13C me-
tabolites, the T2-hyperintense lesion was also compared with
the contralateral brain (voxels with nonhyperintense tissue
on the opposite side of the T2 lesion).
Immediately following the scan, tumor-bearing animals
were sacrificed and harvested for their brains, which were
fixed in phosphate-buffered 4% formalin. Samples were then
dehydrated by graded ethanol and embedded in Paraplast
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Figure 1: Representative anatomical images from a rat (n � 8 total) bearing orthotopic DIPG. T2-weighted images in sagittal (a) and axial
(b) planes demonstrated a T2-hyperintense lesion through the brainstem.,e corresponding axial post-Gd T1-weighted image (c) exhibited
no contrast enhancement. Horizontal dashed lines in (a) delimit the 5.4mm axial slice of 13C MRSI data, presented in Figure 2. ,e yellow
boundary in (a) and (b) indicates the location of pons.
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Plus wax (McCormick Scientific). 5 µm sections were ex-
amined following haematoxylin and eosin (H&E) staining.
3. Results and Discussion
Representative anatomical data from a rat injected with
DIPG cells are shown in Figure 1, with panel (a) providing
an overview of an orthotopic lesion around the brainstem on
a sagittal T2-weighted image. ,e corresponding axial T2-
weighted image exhibited hyperintensity throughout the
cerebellum and pons (Figure 1(b)), while no contrast en-
hancement was visible from the post-Gd T1-weighted image
acquired at the same location (Figure 1(c)).
,e axial T2-weighted image in Figure 2(a) depicts a 13C
MRSI grid superimposed over the brainstem. ,e corre-
sponding hyperpolarized 13C spectra from the same animal
(Figure 2(b)) demonstrated the spatial distribution of high
13C-labeled lactate and pyruvate signals over the entire
brainstem region. Illustrative of the full cohort, these
hyperpolarized 13CMRSI data demonstrated levels of lactate
in the T2 lesions (pink voxels; Figures 2(a) and 2(b)) that
were elevated relative to the contralateral normal brain (blue
voxels; Figures 2(a) and 2(b)).
Metabolite parameters derived from hyperpolarized
data are compared between DIPG xenografts and healthy
control brains in Table 1. ,e T2-hyperintense tumors
exhibited highly elevated metabolism compared to both
healthy controls and the contralateral hemisphere, which
may contain infiltrating tumor. ,e ratios of lactate-to-
pyruvate, lactate-to-total carbon, and normalized lactate in
T2 lesions (0.70 ± 0.24, 0.36 ± 0.08, and 2.9 ± 1.1, resp.)
were significantly higher than the corresponding values in
the healthy normal brain (0.20 ± 0.06, 0.14 ± 0.03, and 1.1 ±
0.25, resp.). ,e normalized lactate map in Figure 2(c)
shows the differential production of lactate between the
DIPG xenograft and tissue in the contralateral hemisphere.
From the corresponding H&E-stained slice, there was
observed infiltrative, viable tumor that recapitulated the
histopathology of pediatric DIPG (Figure 2(d)). In con-
trast, the normalized pyruvate was found to be similar
across both regions and comparable to the healthy brain
(Table 1).
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Figure 2: Representative hyperpolarized 13C data from a rat (n � 8 total) bearing DIPG. (a) Axial T2-weighted image of the brainstem with
a spectral grid overlay for 3D 13C MRSI data. Pink and light blue boxes represent voxels encompassing the T2-hyperintense lesion and
contralateral brain tissue, respectively. (b) ,e corresponding hyperpolarized 13C spectra with an in-plane spatial resolution of
2× 2× 5.4mm3. Voxels encompassing the T2-hyperintense lesion (pink boxes) exhibited elevated lactate levels compared to those of the
contralateral brain tissue (light blue boxes). (c) ,e map of normalized lactate shows elevated lactate signal in DIPG. (d),e corresponding
slice from H&E staining (top) and the zoomed-in H&E image (bottom) demonstrate infiltrative, viable DIPG.,e blue and green arrows in
(c) and (d) indicate pons and cerebellum of the rat brain, respectively.
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In order to assess the ability to observe longitudinal
changes in metabolism, hyperpolarized 13C MRSI data were
obtained from an additional single animal imaged over a pe-
riod of 7 days in the course of tumor development (Figure 3).
,e longitudinal change in normalized lactate signal and T2-
hyperintensity are shown in Figure 3. Normalized lactate from
the 13C spectral data imaged at 42, 46, and 48 days from
implantation were 1.2± 0.2, 2.5±0.1, and 3.5±1.0, respectively.
,ese data show a severalfold increase in the metabolic ab-
normality associated with the evolution of the anatomic lesion.
,is study has demonstrated the feasibility of using
hyperpolarized 13C metabolic imaging to assess in vivo
metabolism in orthotopic brainstem xenografts that contain
patient-derived primary DIPG cells. By using hyperpolarized
[1-13C]-pyruvate in conjunction with rapid 3D MRSI acqui-
sition techniques, it was shown that nonenhancing brainstem
glioma can be evaluated on the basis of real-time molecular
data, as an initial step towards noninvasive disease charac-
terization. To the best of our knowledge, this is the first study
to apply hyperpolarized 13C techniques in brainstem tumor as
well as in nonenhancing brain tumor.
An important feature of the orthotopic murine tumor
model adopted here was its ability to recapitulate aspects of
disease observed in patients. With regard to imaging, the
longitudinal data revealed a similar pattern of disease pro-
gression, wherein cells implanted in the pons spread from
a localized lesion to the cerebellum after a period of rapid
growth, and without visible enhancement [12, 13]. Analysis of
the resected brain by histopathology confirmed viable DIPG
in the pons, along with the associated cerebellar infiltration,
which supported findings from metabolic imaging indicating
temporal changes.
Because DIPG is radiographically characterized by poorly
perfused and faintly enhancing heterogeneous lesions, its
diagnostic assessment remains challenging. In this context, the
relative elevation of lactate in nonenhancing lesions compared
to healthy control tissue was a defining feature that may hold
diagnostic value for patients as an in vivomarker of disease. As
these tumors frequently display high levels of LDHA [14, 15]
that preferentially convert pyruvate to lactate, imaging of
hyperpolarized [1-13C]-pyruvate might offer a targeted means
of monitoring tumor growth and disease status. ,e nuclear
polarization techniques implemented here provided sufficient
signal enhancement to detect real-time pyruvate-to-lactate
conversion in the brainstem with high sensitivity, as well as
distinguish longitudinal variation in metabolism from grow-
ing tumor over relatively brief intervals. Based on the quality
and spatial resolution of the 13C spectra achieved via hardware
and sequence performance, it was possible to evaluate met-
abolic differences between T2-hyperintense lesions and con-
tralateral brain tissue.
Although our focus was on demonstrating feasibility, we
believe that a promising application of this technique may be
monitoring response to treatment in patients with DIPG,
Table 1: Summary of 13C metabolite quantification. Metabolite values are mean± SD.
Lactate/pyruvatea,b Lactate/total carbona,b Normalized lactatea,b Normalized pyruvate
T2-hyperintense lesion (n � 8) 0.70± 0.24 0.36± 0.08 2.9± 1.1 1.0± 0.29
Contralateral brain (n � 8) 0.28± 0.11 0.18± 0.07 1.1± 0.33 1.1± 0.35
Healthy rat brain (n � 5) 0.20± 0.06 0.14± 0.03 1.2± 0.25 1.1± 0.25
aSignificant difference between T2-hyperintense lesion and contralateral brain (p< 0.001). bSignificant difference between T2-hyperintense lesion and healthy
rat brain (p< 0.002).
Figure 3: Longitudinal 13C spectral data showing normalized lactate from a rat imaged at 42, 46, and 48 days from implantation (left to
right). ,e top row displays the map of normalized lactate overlaid on the same T2-weighted images of the bottom row. ,ese data show
a several-fold increase in the metabolic abnormality associated with the evolution of the anatomic lesion.,e red arrows indicate T2 lesion in
the brainstem, while blue and green arrows indicate pons and cerebellum of the rat brain, respectively. ,e tumor initially developed in the
pons and diffused across the cerebellum.
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given the inadequacy of conventional MR imaging. By
administering [1-13C]-pyruvate as a hyperpolarized sub-
strate with measurable conversion to [1-13C]-lactate, studies
have already managed to provide evidence for both locali-
zation of malignant tissue and treatment-induced reduction
of metabolic activity arising from growth arrest or apoptosis
[16, 17]. A recent study has demonstrated the first appli-
cation of hyperpolarized 13C MR metabolic imaging in
patients with supratentorial glioma and presented the safety
and feasibility of using hyperpolarized [1-13C]-pyruvate to
evaluate in vivo brain metabolism [18]. Perhaps the greatest
technical challenge to translating hyperpolarized imaging to
the clinic for diffusing intrinsic pontine glioma is ensuring
adequate SNR in the brainstem, where the surrounding
tissue is less perfused and far removed from coil elements.
While several single- and multivoxel 1H spectroscopy
studies have indicated that 1H magnetic resonance spectros-
copy (MRS) may be useful for assessing disease progression
andmonitoring response to treatment [19–22], the acquisition
of proton spectra in the infratentorial region is generally
challenging due to susceptibility effects around the brainstem
region and confounded by overlapping lipid peaks that reflect
contamination from the surrounding skull. ,e susceptibility
effects encountered in 13C MR are considerably smaller rel-
ative to 1H MR by virtue of the 13C gyromagnetic ratio, which
is one-fourth that of 1H. ,e proposed method of assessing
real-time metabolism using hyperpolarized 13C MRSI, com-
bined with anatomical MRI and 1H MRS, may provide com-
plementary information that is of value in assessing disease
status and response to treatment in DIPG.
Interestingly, the ratio of lactate-to-pyruvate in the non-
enhancing T2 lesion from this study (0.70±0.24) was signifi-
cantly smaller than that of enhancing tumor from supratentorial
orthotopic glioblastoma xenografts in a previous study (1.0±
0.36) (p< 0.02, unpaired t-test), while it remained similar
between contralateral brainstem tissue (0.28±0.11) and con-
tralateral supratentorial brain tissue (0.29± 0.17) [11]. Future
studies will attempt to elucidate the molecular and pathologic
mechanisms that produce different characteristics in pyruvate
metabolism depending on the type of glioma.
4. Conclusions
,e results from this study characterized pyruvate and lactate
metabolism in orthotopic DIPG xenografts and suggest that
hyperpolarized 13C pyruvate MRSI is a promising noninvasive
imaging tool for the in vivo monitoring of biochemical pro-
cesses in DIPG.
Data Availability
,e data used to support the findings of this study are
available from the corresponding author upon request.
Disclosure
An earlier version of this work was presented as a conference
abstract at the Joint Annual Meeting ISMRM-ESMRMB on
10–16 May 2014 in Milan, Italy.
Conflicts of Interest
,ere are no conflicts of interest to report in this study.
Acknowledgments
Ilwoo Park was supported by an NCI training grant in
translational brain tumor research (T32 CA151022), a dis-
covery grant from the American Brain Tumor Association,
and Jacobsen Fund from Research Evaluation and Allocation
Committee (REAC). Support for the research studies came from
National Institutes of Health (NIH) (Grant nos. R01EB013427
and P41EB013598), National Research Foundation (NRF) of
Korea grant, funded by Ministry of Science and ICT (Grant
no. 2017R1C1B5018396) and grants from Chonnam National
University Hospital Biomedical Research Institute
(CRI18019-1 and CRI18094-2). ,e authors gratefully ac-
knowledge the guidance of Dr. Sarah J. Nelson in accom-
plishing this study.
References
[1] K. J. Cohen, R. L. Heideman, T. Zhou et al., “Temozolomide in
the treatment of children with newly diagnosed diffuse intrinsic
pontine gliomas: a report from the Children’s OncologyGroup,”
Neuro-Oncology, vol. 13, no. 4, pp. 410–416, 2011.
[2] P. Rao, “Role of MRI in paediatric neurooncology,” European
Journal of Radiology, vol. 68, no. 2, pp. 259–270, 2008.
[3] D. Hargrave, N. Chuang, and E. Bouffet, “Conventional MRI
cannot predict survival in childhood diffuse intrinsic pontine
glioma,” Journal of Neuro-Oncology, vol. 86, no. 3, pp. 313–
319, 2008.
[4] D. Brenner, C. Elliston, E. Hall, andW. Berdon, “Estimated risks
of radiation-induced fatal cancer from pediatric CT,” American
Journal of Roentgenology, vol. 176, no. 2, pp. 289–296, 2001.
[5] R. A. Kleinerman, “Cancer risks following diagnostic and
therapeutic radiation exposure in children,” Pediatric Radi-
ology, vol. 36, no. 2, pp. 121–125, 2006.
[6] M. S. Aboian, D. A. Solomon, E. Felton et al., “Imaging
characteristics of pediatric diffuse midline gliomas with his-
tone H3 K27M mutation,” American Journal of Neuroradi-
ology, vol. 38, no. 4, pp. 795–800, 2017.
[7] J. H. Ardenkjaer-Larsen, B. Fridlund, A. Gram et al., “Increase
in signal-to-noise ratio of >10,000 times in liquid-state NMR,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 100, no. 18, pp. 10158–10163, 2003.
[8] S. J. Nelson, J. Kurhanewicz, D. B. Vigneron et al., “Metabolic
imaging of patients with prostate cancer using hyperpolarized
[1-(1)(3)C]pyruvate,” Science Translational Medicine, vol. 5,
no. 198, p. 198, 2013.
[9] R. Hashizume, I. Smirnov, S. Liu et al., “Characterization of
a diffuse intrinsic pontine glioma cell line: implications for
future investigations and treatment,” Journal of Neuro-
Oncology, vol. 110, no. 3, pp. 305–313, 2012.
[10] I. Park, P. E. Larson, M. L. Zierhut et al., “Hyperpolarized 13C
magnetic resonance metabolic imaging: application to brain
tumors,” Neuro-Oncology, vol. 12, no. 2, pp. 133–144, 2010.
[11] I. Park, S. Hu, R. Bok et al., “Evaluation of heterogeneous
metabolic profile in an orthotopic human glioblastoma xe-
nograft model using compressed sensing hyperpolarized 3D
13C magnetic resonance spectroscopic imaging,” Magnetic
Resonance in Medicine, vol. 70, no. 1, pp. 33–39, 2013.
Contrast Media & Molecular Imaging 5
[12] V. Caretti, M. Bugiani, M. Freret et al., “Subventricular spread
of diffuse intrinsic pontine glioma,” Acta Neuropathologica,
vol. 128, no. 4, pp. 605–607, 2014.
[13] J. Yoshimura, K. Onda, R. Tanaka, and H. Takahashi,
“Clinicopathological study of diffuse type brainstem gliomas:
analysis of 40 autopsy cases,” Neurologia Medico-Chirurgica,
vol. 43, no. 8, pp. 375–382, 2003.
[14] A. M. Saratsis, M. Kambhampati, K. Snyder et al., “Com-
parative multidimensional molecular analyses of pediatric
diffuse intrinsic pontine glioma reveals distinct molecular
subtypes,” Acta Neuropathologica, vol. 127, no. 6, pp. 881–895,
2014.
[15] O. Warburg, “On the origin of cancer cells,” Science, vol. 123,
no. 3191, pp. 309–314, 1956.
[16] K. Brindle, “New approaches for imaging tumour responses to
treatment,” Nature Reviews Cancer, vol. 8, no. 2, pp. 94–107,
2008.
[17] C. S. Ward, H. S. Venkatesh, M. M. Chaumeil et al., “Non-
invasive detection of target modulation following phospha-
tidylinositol 3-kinase inhibition using hyperpolarized 13C
magnetic resonance spectroscopy,” Cancer Research, vol. 70,
no. 4, pp. 1296–1305, 2010.
[18] I. Park, P. E. Z. Larson, J. W. Gordon et al., “Development of
methods and feasibility of using hyperpolarized carbon-13
imaging data for evaluating brain metabolism in patient
studies,” Magnetic Resonance in Medicine, vol. 80, no. 3,
pp. 864–873, 2018.
[19] A. Laprie, A. Pirzkall, D. A. Haas-Kogan et al., “Longitudinal
multivoxel MR spectroscopy study of pediatric diffuse
brainstem gliomas treated with radiotherapy,” International
Journal of Radiation Oncology, Biology, Physics, vol. 62, no. 1,
pp. 20–31, 2005.
[20] A. Panigrahy, M. D. Nelson, J. L. Finlay et al., “Metabolism of
diffuse intrinsic brainstem gliomas in children,” Neuro-
Oncology, vol. 10, no. 1, pp. 32–44, 2008.
[21] E. A. Steffen-Smith, D. J. Venzon, R. S. Bent et al., “Single and
multi-voxel proton spectroscopy in pediatric patients with
diffuse intrinsic pontine glioma,” International Journal of
Radiation Oncology, Biology, Physics, vol. 84, no. 3, pp. 774–
779, 2012.
[22] F. Yamasaki, K. Kurisu, Y. Kajiwara et al., “Magnetic reso-
nance spectroscopic detection of lactate is predictive of a poor
prognosis in patients with diffuse intrinsic pontine glioma,”
Neuro-Oncology, vol. 13, no. 7, pp. 791–801, 2011.
6 Contrast Media & Molecular Imaging
